Wearable Cardiac Devices Market Size to Hit USD 32.16 Bn by 2034

The global wearable cardiac devices market size was valued at USD 3.75 billion in 2024 and is predicted to increase from USD 4.68 billion in 2025 to approximately USD 32.16 billion by 2034, expanding at a CAGR of 23.97% during the forecast period. Rising awareness about preventive healthcare, growing geriatric population, and increasing health expenditures are fueling the market’s rapid expansion.

Wearable Cardiac Devices Market Size 2025 to 2034

• 2024: USD 3.75 billion

• 2025: USD 4.68 billion

• 2034: USD 32.16 billion

• CAGR (2025–2034): 23.97%

Read Also: Neurotech Devices Market

Wearable Cardiac Devices Market Key Takeaways

• North America dominated the market with a 61% share in 2024.

• Asia Pacific is expected to witness the fastest growth from 2025 to 2034.

• By product:

  • Defibrillators led the market in 2024.

  • Patches are anticipated to record significant growth during the forecast period.

• By application: Home healthcare was the leading and fastest-growing segment in 2024.

How AI Integration is Transforming the Market

Artificial Intelligence (AI) is revolutionizing wearable cardiac devices by

• Enhancing diagnostic precision through real-time cardiac monitoring and anomaly detection.

• Improving battery efficiency and power optimization for long-term usage.

• Accelerating data processing, ensuring faster and more accurate health insights.

• Enabling telehealth integration, allowing remote consultations, patient engagement, and early intervention.

AI-driven wearables support personalized cardiac care, reduce hospital visits, and expand access to healthcare in underserved communities.

Market Scope

Market Overview

Wearable cardiac devices, a subset of wearable healthcare technologies, are designed to monitor and track cardiac health parameters such as heart rate, rhythm, and activity levels. Equipped with advanced sensors and connectivity features, these devices provide real-time health insights that support early detection, preventive care, and disease management. They are widely used in applications ranging from home healthcare to remote patient monitoring (RPM), reducing the burden on hospitals and improving patient outcomes.

Market Dynamics

Drivers

• Cardiovascular diseases remain the leading cause of global deaths, with ~620 million people affected worldwide.

• Increasing demand for personalized care and real-time monitoring.

Restraints

• Regulatory challenges and varying global standards.

• Limited awareness in certain regions about device benefits and reliability.

Opportunities

• Technological advancements in defibrillators, patches, and RPM platforms.

• Growing AI-powered cardiac monitoring patches and consumer-grade devices.

• Expansion of telemedicine and digital health ecosystems.

Product Insights

• Defibrillators dominated in 2024, widely adopted for sudden cardiac death prevention.

• Patches expected to grow fastest due to comfort, affordability, non-invasiveness, and AI integration.

Application Insights

• Home healthcare led the market in 2024, fueled by rising adoption post-COVID-19.

• Remote patient monitoring (RPM) is gaining traction, particularly in underserved and rural regions.

Wearable Cardiac Devices Market Companies

• Heartbit Holdings Plc.

• Qardio, Inc.

• GE Healthcare (BioTelemetry, Inc.)

• iRhythm Technologies, Inc.

• Boston Scientific (Preventice Solutions, Inc.)

• ZOLL Medical Corporation (Asahi Kasei Corporation)

• Medtronic plc

• Koninklijke Philips N.V.

• Vital Connect, Inc.

• Baxter

• About
• Latest Posts

ritika jankar

Latest posts by ritika jankar (see all)

• Sterilization Equipment Market Size to Reach USD 36.16 Bn by 2034 - September 19, 2025
• Wearable Cardiac Devices Market Size to Hit USD 32.16 Bn by 2034 - September 19, 2025
• Neurotech Devices Market Size to Hit USD 55.79 Billion by 2034 - September 19, 2025